Literature DB >> 19756450

Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands.

Krisztian Nemeth1, Balazs Mayer, Eva Mezey.   

Abstract

Bone marrow-derived stromal cells (BMSCs, or as they are frequently referred to as mesenchymal stem cells) have been long known to support hematopoiesis and to regenerate bone, cartilage, and adipose tissue. In the last decade, however, a vast amount of data surfaced in the literature to suggest new roles for these cells including tissue regeneration and immunomodulation. A great number of review articles appeared that summarize these new data and focus on different aspects of the physiology of these cells. In this present short review, we will try to summarize the available data based on both mouse and human cells describing how the function of BMSCs might be affected by an infectious environment. These data strongly support the idea that different toll-like receptor ligands can lead to substantial changes in the function of BMSCs that affect their proliferation, apoptosis, migration, and their production and release of immunomodulatory factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756450      PMCID: PMC2928254          DOI: 10.1007/s00109-009-0523-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  33 in total

Review 1.  Mesenchymal stem cells in health and disease.

Authors:  Antonio Uccelli; Lorenzo Moretta; Vito Pistoia
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

Review 2.  Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation.

Authors:  Meindert Crop; Carla Baan; Willem Weimar; Martin Hoogduijn
Journal:  Transpl Int       Date:  2008-11-01       Impact factor: 3.782

Review 3.  Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.

Authors:  A Nasef; N Ashammakhi; L Fouillard
Journal:  Regen Med       Date:  2008-07       Impact factor: 3.806

4.  Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation.

Authors:  Mikael Sundin; Anna Lindblom; Claes Örvell; A John Barrett; Berit Sundberg; Emma Watz; Agneta Wikman; Kristina Broliden; Katarina Le Blanc
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

5.  Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens.

Authors:  Fabio Morandi; Lizzia Raffaghello; Giovanna Bianchi; Francesca Meloni; Annalisa Salis; Enrico Millo; Soldano Ferrone; Vincenzo Barnaba; Vito Pistoia
Journal:  Stem Cells       Date:  2008-02-21       Impact factor: 6.277

6.  Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Christian Lutz; Tobias V Lanz; Isabel Tritschler; Alexandra Köppel; Eva Tolosa; Maik Hoberg; Jan Anderl; Wilhelm K Aicher; Michael Weller; Wolfgang Wick; Michael Platten
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

7.  Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.

Authors:  Chan Xie; Yu-Bao Zheng; Hai-Peng Zhu; Liang Peng; Zhi-Liang Gao
Journal:  Cell Biol Int       Date:  2009-01-19       Impact factor: 3.612

8.  Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

Authors:  Krisztián Németh; Asada Leelahavanichkul; Peter S T Yuen; Balázs Mayer; Alissa Parmelee; Kent Doi; Pamela G Robey; Kantima Leelahavanichkul; Beverly H Koller; Jared M Brown; Xuzhen Hu; Ivett Jelinek; Robert A Star; Eva Mezey
Journal:  Nat Med       Date:  2008-11-21       Impact factor: 53.440

Review 9.  Mesenchymal stem cells: flip side of the coin.

Authors:  Pravin J Mishra; Prasun J Mishra; John W Glod; Debabrata Banerjee
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

Review 10.  Stromal cells.

Authors:  Muriel Vayssade; Marie-Danielle Nagel
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  38 in total

1.  Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.

Authors:  Jeffery J Auletta; Robert J Deans; Amelia M Bartholomew
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

2.  Characterization of progenitor cells in pulps of murine incisors.

Authors:  A Balic; M Mina
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

Review 3.  Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome.

Authors:  Jeffrey E Gotts; Michael A Matthay
Journal:  Clin Chest Med       Date:  2014-09-24       Impact factor: 2.878

4.  Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.

Authors:  Jae W Lee; Anna Krasnodembskaya; David H McKenna; Yuanlin Song; Jason Abbott; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

5.  Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury.

Authors:  Jayakumar Thangavel; Asrar B Malik; Harold K Elias; Sheeja Rajasingh; Andrew D Simpson; Premanand K Sundivakkam; Stephen M Vogel; Yu-Ting Xuan; Buddhadeb Dawn; Johnson Rajasingh
Journal:  Am J Pathol       Date:  2014-06-12       Impact factor: 4.307

6.  Characterization and function of histamine receptors in human bone marrow stromal cells.

Authors:  Krisztian Nemeth; Todd Wilson; Balazs Rada; Alissa Parmelee; Balazs Mayer; Edit Buzas; Andras Falus; Sharon Key; Tamas Masszi; Sarolta Karpati; Eva Mezey
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

7.  Functional effects of TGF-β1 on mesenchymal stem cell mobilization in cockroach allergen-induced asthma.

Authors:  Peisong Gao; Yufeng Zhou; Lingling Xian; Changjun Li; Ting Xu; Beverly Plunkett; Shau-Ku Huang; Mei Wan; Xu Cao
Journal:  J Immunol       Date:  2014-04-07       Impact factor: 5.422

Review 8.  Macrophage polarization in response to epigenetic modifiers during infection and inflammation.

Authors:  Urmi Patel; Sheeja Rajasingh; Saheli Samanta; Thuy Cao; Buddhadeb Dawn; Johnson Rajasingh
Journal:  Drug Discov Today       Date:  2016-08-21       Impact factor: 7.851

9.  A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

Authors:  Ruth S Waterman; Suzanne L Tomchuck; Sarah L Henkle; Aline M Betancourt
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

10.  Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.

Authors:  Jeffrey E Gotts; Jason Abbott; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.